Vascular Biogenics: A Microcap With A Potential Blockbuster Cancer Therapy In Phase 3 – Seeking Alpha

Vascular Biogenics: A Microcap With A Potential Blockbuster Cancer Therapy In Phase 3Seeking Alpha$150m market cap, and enough cash to get into early 2019, likely beyond the phase 3 and several other catalysts. Nearly midway through a phase-3 pivot trial that should finish in 2018 for a brain cancer drug that may compare favorably to […]

from WordPress http://ift.tt/2p2s7Pq
via IFTTT

Newer Post Older Post